Global Oncology/Cancer Drugs Market


  • Type: Oncology area
  • Published : March 2021
  • Region: Worldwide
  • Country: Other
  • Report ID : 100

  • Format: PPT, PDF

Global Oncology/Cancer Drugs Market: Segmented by Drug Class (Cytotoxic Drugs, Targeted Drugs, Hormonal Drugs and Others), by Therapy (Chemotherapy, Targeted Therapy and Immunotherapy), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies) and by Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America) – Growth, Trends, and Forecasts (2019 – 2028)


Report Overview

The global oncology drugs market size stood at around USD 141.33 billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Oncology is a key driver for the growth of the pharmaceutical industry. It is estimated to account for about 30 percent of its product pipeline and 25 percent of pharmaceutical industry revenue by 2020. The market is undergoing a significant growth rate due to the factors such as the rising prevalence of different cancers, increasing new drug launch and product approvals, and growing research activities by the pharma companies in this field. For instance, according to the American Cancer Society, there will be around 1,806,590 cancer patients in the U.S. alone by 2020, a 31% increase from 2010. The oncology cancer drugs are primarily used to lower the total number of cancer cells in the body, shrink the tumor size, and reduce the symptoms.

Market Drivers

Rise in incidence of cancer across the globe in a market drivers. Worldwide, the cancer incidence rate has increased to make it the second leading cause of death after cardiovascular disorders. Environmental factors such as tobacco smoking, changing diet patterns, urbanization, and extended post-reproductive lifespan are responsible for this phenomenon. As per World Health Organization (WHO), cancer is a growing burden and the number of new cancer cases is going to rise from 18.1 million in 2018 to 29.4 million by 2040. Therefore, the increasing prevalence of cancer is expected to boost the demand for the global oncology cancer drugs market during the forecast period. Furthermore, the rising awareness regarding cancer among the population is anticipated to favor the global market in the upcoming years.

The increase in geriatric population, increase in the government expenditure on healthcare and presence of strong pipeline of drugs also drives the market growth.

Major Oncology Types

The major types of oncology includes lung cancer, blood cancer, colorectal cancer, breast cancer, prostate cancer and others. The breast cancer is to exhibit significant CAGR during the forecast period. The market for oncology drugs for breast cancer segment is expected to grow at a faster CAGR. Growing prevalence of breast cancer, rising awareness, and increased breast cancer therapeutics launches, and extensive R&D investments by the key market players are some of the factors responsible for its faster growth during the forecast period. For instance, in April 2019, Emcure Pharmaceuticals launched generic metastatic breast cancer treatment drug under the brand name Eribilin in India.

The others segment, on the other hand, accounts for the maximum share in 2019 and include various other cancer types such as bladder cancer, kidney cancer, thyroid cancer, uterine cancer, pancreatic cancer, lymphoma, etc.

1. Global Oncology Drugs Market Overview…………………………………………
A. Market Size
2. Market Growth Drivers……………………………………………………..………..
A. Rise in incidence of cancer across the globe
B. Increasing Geriatric Population
C. Increase in government expenditures on healthcare
3. Major Oncology Types…………………………………………………………………
A. Lung Cancer
B. Blood Cancer
C. Colorectal Cancer
D. Breast Cancer
E. Prostate Cancer
F. Others
4. Oncology Drugs Market Segmentation……………..……………………………….
A. By Drug Class
I. Cytotoxic Drugs
II. Targeted Drugs
III. Hormonal Drugs
IV. Others
B. By Therapy
I. Chemotherapy
II. Targeted Therapy
III. Immunotherapy
C. By Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
D. By Geography
I. North America Market Analysis
II. Europe Market Analysis
III. Asia-Pacific Market Analysis
IV. Middle-East and Africa Market Analysis
V. South America Market Analysis
5. Oncology Major Drugs Market Share………………………………………………
A. Key Findings
B. Market Analysis, Insights and Forecast
6. Competitive Landscape………………………………………………………….…….
A. Major Players
B. Products in Pipeline
7. Key Company Profiles…………………………………………………………………..
A. F. Hoffmann-La Roche Ltd Company overview, Product & Services, Strategies & Financials
B. Genentech Inc Company overview, Product & Services, Strategies & Financials
C. Novartis AG Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape…………………………..……
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth………………………………………………………
A. Key Industry Developments of Oncology drugs market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class

Based on drug class, the market includes cytotoxic drugs, targeted drugs, hormonal drugs, and others. The targeted drugs segment held a dominant oncology drugs market share of the global market in 2019. The chemotherapy or targeted therapy is aimed at the disease while minimizing the off-target side-effects caused to the normal cells. This leads to its higher adoption among the other drugs in the market, leading to its dominance. Furthermore, the rising number of pipeline candidates for this category and the growing number of product approvals are anticipated to fuel the growth of this segment during the forecast period. For instance, in January 2020, Pfizer launched three oncology monoclonal antibody biosimilars treatments – bevacizumab-bvzr (Zirabev), rituximab-pvvr (Ruxience), and trastuzumab-qyyp (Trazimera) in the U.S market.

By Therapy

Based on therapy, the market includes chemotherapy, targeted therapy, and immunotherapy. The targeted therapy segment held a dominant share of the global market in 2019. The higher share of the segment is attributed to the growing adoption and preference for targeted drugs in emerging regions for the treatment of various cancers. This is owing to its ability to target only the cancerous cells and treat certain advanced cancers such as metastatic breast cancer.

The immunotherapy segment, on the other hand, is anticipated to expand with the highest growth rate during the forecast period. The highest growth rate of the segment is due to the launch of various drugs of this type by the key industry players and extensive research and development by the research organizations.

By Distribution Channel

In terms of distribution channels, the market is segmented into hospital pharmacies, retail pharmacies, and others. The hospital pharmacies segment is projected to have the dominant during the forecast period. The increasing prescription of medications at hospitals due to more frequent diagnoses at these institutions is the reason for the dominance of this segment.

Moreover, the online pharmacies segment is likely to expand with the highest CAGR owing to its rising popularity due to their ease and convenience.

By Region:

The market size in North America stood at USD 65.63 billion in 2019. Growing incidence and rising prevalence of cancer in the U.S., coupled with new product launches in the region is responsible for the dominance of the region. Europe is anticipated to account for the second-largest share in the global market. The high growth countries including U.K., Germany, France, Italy, and Spain would contribute to the growth of the European market owing to increasing cancer burden. The market in Asia Pacific is expected to exhibit faster growth rate owing to the increasing awareness among the population. The growing prevalence of cancer and rising healthcare expenditure will favour growth in the region. Latin America & the Middle East & Africa are likely to witness a limited growth rate due to less awareness and affordability to high-cost biologic drugs.

Top Major Players

Hoffmann-La Roche Ltd, Genentech, Inc., and Novartis AG dominated the global oncology market and will continue to dominate in the upcoming years. Their dominance is driven by a strong oncology product portfolio, key strategic business acquisitions, and robust product pipelines. These companies have a wider geographic presence and also are actively involved in research and development resulting in strong regulatory approvals. For instance, in April 2020, Roche announced the launch of immunotherapy drug Atezolizumab for the treatment of metastatic triple-negative breast cancer (TNBC) in India.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.

    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements